Journal of the American Society of Nephrology

publication venue for

Incidence and Risk Factors for Obesity and Short Stature in Childhood Nephrotic Syndrome: A Prospective Cohort Study 2023
Long-Term Kidney Outcomes in Children with Posterior Urethral Valves: A Population-Based Cohort Study 2023
Long-Term Outcomes After Pediatric Non-Dialysis-Treated AKI: A Population-Based Cohort Study 2023
Prevalence of Masked Hypertension and Its Association with Target Organ Damage in Children: A Systematic Review and Meta-Analysis 2023
Risk of Target Organ Damage in Pediatric CKD Patients with Ambulatory Hypertension: A Systematic Review and Meta-Analysis 2023
Sleep-Disordered Breathing, Risk of Target Organ Injury, and Role of Obesity in Youth Referred for Hypertension Disorders 2023
The Utilization of Gabapentin and Pregabalin for the Treatment of CKD-Associated Pruritus and Other Indications in Manitoba 2023
A Report on Home Hemodialysis Training Time in Patients With Kidney Failure Using the Quanta SC plus Hemodialysis Device 2022
Impact of Dialysate Flow Rates on Dialysis Adequacy: A Systematic Review and Meta-Analysis 2022
Multi-Ancestry Proteo-Genomic Association Study of eGFR 2022
Patient Navigators for CKD and Kidney Failure: A Systematic Review 2022
Temporal Trends in Prevalence of Blood Pressure Screening and Hypertension After Introduction of Clinical Practice Guidelines on Hypertension in Canadian Children: A Time-Series Analysis 2022
Adverse Events Following Rituximab Infusion in Children with Nephrotic Syndrome: A Systematic Review 2021
Cardiovascular Drug Use After AKI Among Hospitalized Patients with a History of Myocardial Infarction: A Population-Based Study 2021
High-Throughput Analysis of Changes in Protein Biomarkers During Hemodialysis 2021
Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba, Canada 2021
Polypharmacy and Potentially Inappropriate Medication Use in Patients with CKD Managed in Canadian Primary 2021
Prevalence of Polypharmacy and Associated Adverse Health Outcomes in Patients with CKD: A Systematic Review and Meta-Analysis 2021
Risk of Subclinical-Cardiovascular Outcomes in Children with Ambulatory Hypertension: A Systematic Review and Meta-Analysis 2021
Urine and Plasma Complement Ba Levels During Flares of Nephritis in Patients with ANCA-Associated Vasculitis 2021
Variation in Interpretation of 24-Hour Ambulatory Blood Pressure Monitoring (ABPM) in Children with Confirmed or Suspected Hypertension (HTN) by Canadian Pediatric Nephrologists and Cardiologists 2021
High Urinary Calcium Excretion and Genetic Susceptibility to Hypertension and Kidney Stone Disease 2006
Cardiac disease, vascular disease and medication use in patients with chronic renal insufficiency referred to nephrologists. 2003
Clinical results of an aggressive policy towards fistula placement 2003
Estimating the prevalence of renal insufficiency in seniors requiring long-term care 2003
Hemoglobin variability in hemodialysis patients: Impact of an anemia management protocol. 2003
Incidence of diabetes mellitus after diarrhea-associated hemolytic uremic syndrome: A systematic review and meta-analysis 2003
Metabolic complications in patients with chronic renal insufficiency referred to nephrologists. 2003
Midodrine is effective for dialysis-induced hypotension: Results of a meta-analysis. 2003
Prevalence of low GFR and proteinuria in the US adult population: National health and nutrition examination survey (NHANES 1999-2000). How many people have CKD? 2003
Stretch-induced Raf-1 activation in mesangial cells requires focal adhesion-cytoskeletal integrity. 2003
The long-term renal prognosis of diarrhea associated hemolytic uremic syndrome: A systematic review, meta-analysis and meta-regression of 3476 children from 49 studies 2003
Walkerton re-visited. 2003
Adenovirus mediated gene transfer of transforming growth factor beta 3 to the rat peritoneum leads to transient ultrafiltration dysfunction. 2002
An outbreak of E.coli O157 : 117 infections due to a contaminated municipal water supply in rural Ontario - Short-term outcome of children developing HUS. 2002
Aranesp (TM) (darbepoetin alfa) administered once every other week treats anemia in patients with chronic kidney disease (CKD) not receiving renal replacement therapy. 2002
Benefit of continuous dialysis in subgroups of acutely ill patients: A retrospective analysis 2002
Costs of epoetin alfa (Eprex (TM)) administration to hemodialysis (HD) patients (pts): A Canadian time and motion study 2002
Does the regular monitoring of access blood flow rate (Qa) improve the survival of AV grafts? Results of a randomized clinical trial. 2002
Relationship between metabolic complications and clearance levels in participants in NHANES III. 2002
Stretch-induced MAPK activation in mesangial cells requires Rho-mediated cytoskeletal reorganization. 2002
Survival analysis of 122-patients with lupus nephritis. 2002
The influence of reported methodological quality on the results of long-term renal prognosis studies of diarrhea associated hemolytic uremic syndrome. 2002
Identification of a unique glomerular factor X activator in murine lupus nephritis. 1997
Increased peritoneal membrane transport is associated with decreased CAPD technique and patient survival. 1997
Measurement of calcium in haemodialysis patients: Comparison of published correction formulae with measured ionized calcium. 1997
Prospective study of infections related to the use of temporary hemodialysis catheters. 1997
Renal effects of intramuscular TGF-beta 1 adenovirus gene therapy in tolerant rats. 1997
Renin-angiotensin system (RAS) genetic polymorphisms and left ventricular hypertrophy (LVH). 1997
The importance of residual renal function for survival in patients on peritoneal dialysis. 1997
The role of heparin-induced thrombocytopenia (HIT) in the thrombocytopenia and thrombotic events in chronic hemodialysis (HD) patients. 1997
Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada 1997
LINKAGE BETWEEN ADEQUACY OF DIALYSIS AND NUTRITION IN CAPD PATIENTS 1995
PATIENT SURVIVAL ON CAPD - COMPARISON BETWEEN CANADA AND THE UNITED-STATES 1995
ADEQUACY OF PERITONEAL-DIALYSIS 1994
DIRECT CLEAVAGE OF COAGULATION FACTOR-X BY GLOMERULI FROM MICE WITH SPONTANEOUS LUPUS NEPHRITIS 1994
IMPACT OF NUTRITION ON CAPD MORTALITY 1994
Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial.. 36:901-910. 2025
Association of Clonal Hematopoiesis of Indeterminate Potential with Cardiovascular Events in Patients with CKD. 2025
Clonal Hematopoiesis of Indeterminate Potential and Progression of CKD. 2025
Adaptive Designs for Clinical Trials in Nephrology.. 36:147-149. 2025
Authors' Reply: Long-Term Kidney Outcomes after Pediatric Acute Kidney Injury: Future Studies Need to Explore Further.. 36:157-158. 2025
Long-Term Kidney Outcomes in Children with Posterior Urethral Valves: A Population-Based Cohort Study.. 35:1715-1725. 2024
Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.. 35:1614. 2024
Long-Term Kidney Outcomes after Pediatric Acute Kidney Injury. 35:1520-1532. 2024
Adverse Long-Term Outcomes following AKI in Hospitalized Children: A MetaAnalysis. 35. 2024
Comparative Effectiveness of Cyclophosphamide and Calcineurin Inhibitors in Childhood Nephrotic Syndrome. 35. 2024
DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT): A Multicenter, Randomized, Double-Blinded, PlaceboControlled Crossover Trial. 35. 2024
Effect of a Perioperative Hypotension Avoidance Strategy vs. a Hypertension Avoidance Strategy on the Risk of AKI. 35:10.1681/asn.2024ct1d6pqm. 2024
Expansion of Visceral Adipose Tissue over 12 Months Is Associated with Changes in Leptin and Fibroblast Growth Factor 23 (FGF-23) and Alterations in Vitamin D Metabolism in Patients with ESKD. 35. 2024
Health Care Resource Utilization and Costs Associated with Childhood Hypertension: A Population-Based Cohort Study. 35. 2024
Kidney Volume and Risk of Incident CKD. 35. 2024
Long-Term Kidney Outcomes in Children and Adolescents with Hypertension. 35. 2024
Mitochondrial DNA Copy Number Is Associated with Incident AKI, CKD, and Inflammatory Biomarkers. 35. 2024
Nedosiran in Pediatric Patients with PH1 ( PHYOX8). 35. 2024
Risk of Target-Organ Damage in Pediatric Patients with CKD and Ambulatory Hypertension: A Systematic Review and Meta-Analysis. 35. 2024
The Effects of Pantoprazole on Kidney Outcomes. 35:901-909. 2024
Kidney Volume and Risk of Incident Kidney Outcomes. 35:1240-1251. 2024
Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team. 35:229-231. 2024
Cell Surface GRP78 and α2M* Are Important Mediators of Tubulointerstitial Fibrosis in CKD. 34:494-494. 2023
Clonal Hematopoiesis of Indeterminate Potential Is Associated with Kidney Disease Progression in a Multi-Cohort Meta-Analysis of Individuals with CKD. 34:473-473. 2023
Incidence and Risk Factors for Obesity and Short Stature in Childhood Nephrotic Syndrome: A Prospective Cohort Study. 34:581-581. 2023
Inhibition of ATP-Citrate Lyase Improves CKD Through Multiple Mechanisms. 34:695-695. 2023
Long-Term Kidney Outcomes in Children with Posterior Urethral Valves: A Population-Based Cohort Study. 34:580-581. 2023
Long-Term Outcomes After Pediatric Non-Dialysis-Treated AKI: A Population-Based Cohort Study. 34:232-232. 2023
Prevalence of Masked Hypertension and Its Association with Target Organ Damage in Children: A Systematic Review and Meta-Analysis. 34:227-227. 2023
Risk of Target Organ Damage in Pediatric CKD Patients with Ambulatory Hypertension: A Systematic Review and Meta-Analysis. 34:227-228. 2023
Sleep-Disordered Breathing, Risk of Target Organ Injury, and Role of Obesity in Youth Referred for Hypertension Disorders. 34:228-228. 2023
The Utilization of Gabapentin and Pregabalin for the Treatment of CKD-Associated Pruritus and Other Indications in Manitoba. 34:518-518. 2023
microRNA (miR)-299a-5p Promotes Apoptosis of Tubular Cells Through Erk5 Inhibition. 34:500-500. 2023
Incorporating Linear Mixed Models into GWAS of Kidney Function Decline. 34:1473-1475. 2023
Association of Primary Versus Rotating Nephrologist Model of Care in Hemodialysis Programs with Patient Outcomes. 34:1155-1158. 2023
Pre-Pregnancy eGFR and the Risk of Adverse Maternal and Fetal Outcomes: A Population-Based Study. 34:656-667. 2023
A Report on Home Hemodialysis Training Time in Patients With Kidney Failure Using the Quanta SC+ Hemodialysis Device. 33:465-465. 2022
Activin A Is a Potential Mediator of TGFβ1-Induced Tubulointerstitial Fibrosis. 33:815-815. 2022
Assessing the Influence of Sex on the CD1 Nephrectomized Streptozoto-cin-Induced Diabetic Kidney Disease Model. 33:101-101. 2022
Association of Bioimpedance Guided Fluid Management in Patients Receiving Peritoneal Dialysis and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. 33:459-459. 2022
Cell Surface GRP78 and Integrin β1 Regulate TGFβ1-Mediated Profibrotic Responses in Diabetic Kidney Disease. 33:104-104. 2022
Impact of Dialysate Flow Rates on Dialysis Adequacy: A Systematic Review and Meta-Analysis. 33:129-129. 2022
Multi-Ancestry Proteo-Genomic Association Study of eGFR. 33:259-259. 2022
Nedosiran in Patients With Primary Hyperoxaluria 1: Interim Results From an Extension Trial (PHYOX3). 33:11-11. 2022
Patient Navigators for CKD and Kidney Failure: A Systematic Review. 33:865-866. 2022
Patient Views Regarding Cannabis Use in CKD and Kidney Failure: A Survey Study. 33:695-695. 2022
Sex and Gender Considerations in Randomized Controlled Trials in Adults Receiving Chronic Dialysis: A Meta-Epidemiologic Study. 33:266-266. 2022
Temporal Trends in Prevalence of Blood Pressure Screening and Hypertension After Introduction of Clinical Practice Guidelines on Hypertension in Canadian Children: A Time-Series Analysis. 33:214-214. 2022
The Impact of Gender Affirming Hormone Therapy on Measures of Kidney Function: A Systematic Review and Meta-Analysis. 33:567-567. 2022
Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study. 33:1903-1914. 2022
Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease. 33:985-995. 2022
Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada. 33:839-849. 2022
Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury. 33:613-627. 2022
Meta-GWAS Reveals Novel Genetic Variants Associated with Urinary Excretion of Uromodulin. 33:511-529. 2022
Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)?. 33:465-466. 2022
Activins Facilitate TGF-β1 Profibrotic Signaling in Kidneys. 32:753-753. 2021
Adverse Events Following Rituximab Infusion in Children with Nephrotic Syndrome: A Systematic Review. 32:608-609. 2021
Authors’ Reply. 32:2681-2682. 2021
Cardiovascular Drug Use After AKI Among Hospitalized Patients with a History of Myocardial Infarction: A Population-Based Study. 32:2-3. 2021
Cell Surface GRP78 Regulates TGF-β1-Mediated Profibrotic Responses via TSP-1 in Diabetic Kidney Disease. 32:239-239. 2021
Follistatin Is a Potential Novel Therapeutic Agent for Essential Hypertension. 32:550-550. 2021
High-Throughput Analysis of Changes in Protein Biomarkers During Hemodialysis. 32:317-317. 2021
Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba, Canada. 32:816-816. 2021
Polypharmacy and Potentially Inappropriate Medication Use in Patients with CKD Managed in Canadian Primary Care. 32:697-697. 2021
Preferences Regarding Treatment with Plasma Exchange for ANCA-Associated Vasculitis: An International Patient Survey. 32:507-507. 2021
Prevalence of Polypharmacy and Associated Adverse Health Outcomes in Patients with CKD: A Systematic Review and Meta-Analysis. 32:734-734. 2021
Risk of Subclinical-Cardiovascular Outcomes in Children with Ambulatory Hypertension: A Systematic Review and Meta-Analysis. 32:13-13. 2021
Variation in Interpretation of 24-Hour Ambulatory Blood Pressure Monitoring (ABPM) in Children with Confirmed or Suspected Hypertension (HTN) by Canadian Pediatric Nephrologists and Cardiologists. 32:836-836. 2021
miR299a-5p Is a Novel Mediator of Fibrosis in Diabetic Kidney Disease. 32:247-247. 2021
Long-Term Kidney Outcomes Following Dialysis-Treated Childhood Acute Kidney Injury: A Population-Based Cohort Study. 32:2005-2019. 2021
Effects of a Knowledge-Translation Intervention on Early Dialysis Initiation: A Cluster Randomized Trial. 32:1791-1800. 2021
Too Little or Too Much? Extracellular Matrix Remodeling in Kidney Health and Disease. 32:1541-1543. 2021
In Search of the Optimal Target for Phosphate Control: Episode 1. 32:526-528. 2021
Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study. 32:424-435. 2021
Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis. 32:239-253. 2021
Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study. 31:2705-2724. 2020
Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial. 31:348-348. 2020
Rivaroxaban Reduces Major Cardiovascular and Limb Events in Patients with CKD and Peripheral Artery Disease with Recent Lower Extremity Revascularization: Insights from VOYAGER PAD. 31:649-649. 2020
Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen. 30:2000-2016. 2019
Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts. 30:1271-1281. 2019
Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial. 30:1294-1304. 2019
Anticoagulant-Related Nephropathy. 29:2787-2793. 2018
Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study. 29:2847-2857. 2018
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. 29:2458-2470. 2018
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. 29:2593-2600. 2018
ESRD among Immigrants to Ontario, Canada: A Population-Based Study. 29:1948-1959. 2018
Diet Patterns—A Neglected Aspect of Hemodialysis Care. 29:1581-1582. 2018
APOL1 Genotype and Renal Function of Black Living Donors. 29:1309-1316. 2018
Blood HER2 and Uromodulin as Causal Mediators of CKD. 29:1326-1335. 2018
Causes of Death after a Hospitalization with AKI. 29:1001-1010. 2018
Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. 29:260-267. 2018
Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac Surgery. 28:3699-3707. 2017
The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death. 28:613-620. 2017
Developmental Origins for Kidney Disease Due to Shroom3 Deficiency. 27:2965-2973. 2016
The Risk of Major Hemorrhage with CKD. 27:2825-2832. 2016
Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials. 27:2529-2542. 2016
Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates. 27:570-578. 2016
Residual kidney function decline and mortality in incident hemodialysis patients. 27:3758-3768. 2016
Characteristics and Outcomes of AKI Treated with Dialysis during Pregnancy and the Postpartum Period. 26:3085-3091. 2015
Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery. 26:3123-3132. 2015
Rehospitalizations and Emergency Department Visits after Hospital Discharge in Patients Receiving Maintenance Hemodialysis. 26:3141-3150. 2015
Kidney Function Alters the Relationship between Postoperative Troponin T Level and Death. 26:2571-2577. 2015
Not All Deaths in CKD Are from a Broken Heart. 26:2307-2308. 2015
SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis. 26:1839-1854. 2015
HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. 26:1701-1710. 2015
β-Blocker Dialyzability and Mortality in Older Patients Receiving Hemodialysis. 26:987-996. 2015
Dialysis. 25:1609-1611. 2014
Urinary Biomarkers of AKI and Mortality 3 Years after Cardiac Surgery. 25:1063-1071. 2014
Economic Evaluation of Frequent Home Nocturnal Hemodialysis Based on a Randomized Controlled Trial. 25:587-594. 2014
Estimated GFR Reporting Influences Recommendations for Dialysis Initiation. 24:1737-1742. 2013
Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery. 23:905-914. 2012
Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis. 23:696-705. 2012
Survival with Three-Times Weekly In-Center Nocturnal Versus Conventional Hemodialysis. 23:687-695. 2012
Global Trends in Rates of Peritoneal Dialysis. 23:533-544. 2012
Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy. 23:313-321. 2012
Dipstick Proteinuria as a Screening Strategy to Identify Rapid Renal Decline. 22:1729-1736. 2011
Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery. 22:1748-1757. 2011
Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Pediatric Cardiac Surgery. 22:1737-1747. 2011
Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease. 22:1353-1364. 2011
Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery. 22:939-946. 2011
β-Catenin Causes Renal Dysplasia via Upregulation of Tgfβ2 and Dkk1. 22:718-731. 2011
The GDNF Target Vsnl1 Marks the Ureteric Tip. 22:274-284. 2011
Reduced Hepatic Synthesis of Calcidiol in Uremia. 21:1488-1497. 2010
The Pathophysiology of the Peritoneal Membrane. 21:1077-1085. 2010
Carotid Endarterectomy Benefits Patients with CKD and Symptomatic High-Grade Stenosis. 21:145-152. 2010
It's about Time. 20:2486-2487. 2009
PKC-β1 Mediates Glucose-Induced Akt Activation and TGF-β1 Upregulation in Mesangial Cells. 20:554-566. 2009
Yin and Yang. 20:8-10. 2009
The Secret of Immortal Time Bias in Epidemiologic Studies. 19:841-843. 2008
BMP Receptor ALK3 Controls Collecting System Development. 19:117-124. 2008
Age Affects Outcomes in Chronic Kidney Disease. 18:2758-2765. 2007
Hemoglobin Variability in Dialysis Patients. 18:2218-2220. 2007
Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney Disease. 18:993-999. 2007
RhoA Activation in Mesangial Cells by Mechanical Strain Depends on Caveolae and Caveolin-1 Interaction. 18:189-198. 2007
Meta-Analysis. 17:2591-2598. 2006
Chronic Kidney Disease and Mortality Risk. 17:2034-2047. 2006
Akt Mediates Mechanical Strain-Induced Collagen Production by Mesangial Cells. 16:1661-1672. 2005
Identifying Individuals with a Reduced GFR Using Ambulatory Laboratory Database Surveillance. 16:1433-1439. 2005
Transient Overexpression of TGF-β1 Induces Epithelial Mesenchymal Transition in the Rodent Peritoneum. 16:425-436. 2005
Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure. 15:3192-3206. 2004
Safety and efficacy of low molecular weight heparins for hem dialysis in patients with end-stage renal failure: A meta-analysis of randomized trials. 15:3192-3206. 2004
Nitric Oxide Inhibits Stretch-Induced MAPK Activation in Mesangial Cells Through RhoA Inactivation. 14:2790-2800. 2003
Protocolized Anemia Management with Erythropoietin in Hemodialysis Patients. 14:2654-2661. 2003
Regular Monitoring of Access Flow Compared with Monitoring of Venous Pressure Fails to Improve Graft Survival. 14:2645-2653. 2003
Development of Renal Disease in People at High Cardiovascular Risk. 14:641-647. 2003
Prognostic Value of Myocardial Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation. 14:431-439. 2003
Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis. 14:431-439. 2003
Acquired Ultrafiltration Dysfunction in Peritoneal Dialysis Patients. 13:2787-2794. 2002
Estimating the Prevalence of Low Glomerular Filtration Rate Requires Attention to the Creatinine Assay Calibration. 13:2811-2816. 2002
Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration - Reply. 13:2812-2816. 2002
Response. 13:2811-2816. 2002
Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis. 13:2331-2337. 2002
Cumulative Risk for Developing End-Stage Renal Disease in the US Population. 13:1635-1644. 2002
Prevalence of Low Glomerular Filtration Rate in Nondiabetic Americans. 13:1338-1349. 2002
Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). 13. 2002
The ADEMEX Study. 13:1415-1418. 2002
The Position of the Polycystic Kidney Disease 1 (PKD1) Gene Mutation Correlates with the Severity of Renal Disease. 13:1230-1237. 2002
Antiangiogenic and Antifibrotic Gene Therapy in a Chronic Infusion Model of Peritoneal Dialysis in Rats. 13:721-728. 2002
Survival Comparison between Hemodialysis and Peritoneal Dialysis Based on Matched Doses of Delivered Therapy. 13:S48-S52. 2002
Gene Transfer of Transforming Growth Factor-β1 to the Rat Peritoneum. 12:2029-2039. 2001
Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis. 12:2158-2162. 2001
Impact of Sodium and Ultrafiltration Profiling on Hemodialysis-Related Symptoms. 12:151-156. 2001
Comparison of Mortality Risk for Dialysis Patients and Cadaveric First Renal Transplant Recipients in Ontario, Canada. 11:917-922. 2000
Identification of a Unique Glomerular Factor X Activator in Murine Lupus Nephritis. 10:2332-2341. 1999
Chapter 1: Clinical practice guidelines for initiation of dialysis. 10:S289-S291. 1999
Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology.. 10 Suppl 13:S289-S291. 1999
Clinical practice guidelines of the Canadian Society of Nephrology for Treatment of Patients with Chronic Renal Failure - Introduction. 10:S287-S288. 1999
Continuous ambulatory peritoneal dialysis - Commentary. 10:904-+. 1999
Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. 9:1285-1292. 1998
Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group.. 9:1285-1292. 1998
Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group.. 8:965-971. 1997
Dietary alteration of dihomogamma-linolenic acid arachidonic acid ratio in a rat 5/6-renal-ablation model. 7:1024-1031. 1996
Dietary alteration of dihomogamma-linolenic acid/arachidonic acid ratio in a rat 5/6-renal-ablation model. The Nutrition & Kidney Disease Research Group.. 7:1024-1031. 1996
Adequacy of dialysis and nutrition in continuous peritoneal dialysis. 7:198-207. 1996
PROBABILITY OF THROMBOSIS OF VASCULAR ACCESS AMONG HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (VOL 4, PG 1809, 1994). 5:121-121. 1994
Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin.. 4:1809-1813. 1994
Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. 2:1634-1639. 1992

has subject area

1103 Clinical Sciences (FoR)
Urology & Nephrology (Science Metrix)

Journal of the American Society of Nephrology Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)